Literature DB >> 15855261

The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study.

Markku Vänttinen1, Pirjo Nuutila, Jussi Pihlajamäki, Kirsti Hällsten, Kirsi A Virtanen, Riikka Lautamäki, Pauliina Peltoniemi, Jukka Kemppainen, Teemu Takala, Antti P M Viljanen, Juhani Knuuti, Markku Laakso.   

Abstract

CONTEXT: The Pro(12)Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene is associated with insulin sensitivity. Obesity is a major risk factor for insulin resistance, but the association of the Pro(12)Ala polymorphism with body weight has been controversial. Furthermore, obesity may modulate the effect of this polymorphism on insulin sensitivity.
OBJECTIVE: The aim of our study was to investigate the effects of the Pro(12)Ala polymorphism on skeletal muscle and adipose tissue glucose uptake (GU) in nonobese and obese subjects.
DESIGN: The design was a cross-sectional study. STUDY
SUBJECTS: The rates of GU were investigated in 124 (72 nonobese and 52 obese; body mass index cutoff point, 27 kg/m(2)) healthy subjects with the euglycemic hyperinsulinemic clamp. Skeletal muscle and adipose tissue GU and skeletal muscle perfusion were measured using fluorine-18-labeled fluorodeoxyglucose, [(15)O]H(2)O, and positron emission tomography.
RESULTS: The rates of skeletal muscle GU were higher in nonobese subjects carrying the Ala(12) allele than in subjects carrying the Pro(12)Pro genotype (P = 0.004), whereas no differences were found in skeletal muscle perfusion between the groups. In contrast, in obese subjects the rates of skeletal muscle GU did not differ between carriers of the Ala(12) allele and carriers of the Pro(12)Pro genotype. No difference in adipose tissue GU was found in either nonobese or obese subjects according to Pro(12)Ala polymorphism.
CONCLUSIONS: We conclude that the Pro(12)Ala polymorphism modulates skeletal muscle GU differently in nonobese and obese subjects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855261     DOI: 10.1210/jc.2005-0101

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Dietary fat, genes and insulin sensitivity.

Authors:  José López-Miranda; Pablo Pérez-Martínez; Carmen Marin; Francisco Fuentes; Javier Delgado; Francisco Pérez-Jiménez
Journal:  J Mol Med (Berl)       Date:  2006-12-15       Impact factor: 4.599

Review 2.  Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?

Authors:  J C Florez
Journal:  Diabetologia       Date:  2008-05-27       Impact factor: 10.122

3.  Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.

Authors:  Jose C Florez; Kathleen A Jablonski; Maria W Sun; Nick Bayley; Steven E Kahn; Harry Shamoon; Richard F Hamman; William C Knowler; David M Nathan; David Altshuler
Journal:  J Clin Endocrinol Metab       Date:  2007-01-09       Impact factor: 5.958

4.  G Allele of the rs1801282 Polymorphism in PPARγ Gene Confers an Increased Risk of Obesity and Hypercholesterolemia, While T Allele of the rs3856806 Polymorphism Displays a Protective Role Against Dyslipidemia: A Systematic Review and Meta-Analysis.

Authors:  Shujin Li; Chuan He; Haiyan Nie; Qianyin Pang; Ruixia Wang; Zhifu Zeng; Yongyan Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-29       Impact factor: 6.055

Review 5.  PPARgamma in human and mouse physiology.

Authors:  Sami Heikkinen; Johan Auwerx; Carmen A Argmann
Journal:  Biochim Biophys Acta       Date:  2007-03-27

6.  Association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma gene and strength athlete status.

Authors:  Agnieszka Maciejewska-Karlowska; Marek Sawczuk; Pawel Cieszczyk; Aleksandra Zarebska; Stanislaw Sawczyn
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

7.  The Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene Modifies the Association of Physical Activity and Body Mass Changes in Polish Women.

Authors:  Aleksandra Zarebska; Zbigniew Jastrzebski; Pawel Cieszczyk; Agata Leonska-Duniec; Katarzyna Kotarska; Mariusz Kaczmarczyk; Marek Sawczuk; Agnieszka Maciejewska-Karlowska
Journal:  PPAR Res       Date:  2014-10-13       Impact factor: 4.964

8.  Role of peroxisome proliferator-activated receptor gamma Pro12Ala polymorphism in human adipose tissue: assessment of adipogenesis and adipocyte glucose and lipid turnover.

Authors:  Prasad G Kamble; Maria J Pereira; Stefan Gustafsson; Per Lundkvist; Casimiro Castillejo-López; Tove Fall; Erik Ingelsson; Jan W Eriksson
Journal:  Adipocyte       Date:  2018-08-14       Impact factor: 4.534

9.  PPARγ2 polymorphism and human health.

Authors:  Weimin He
Journal:  PPAR Res       Date:  2009-04-16       Impact factor: 4.964

10.  The association of gene polymorphisms with athlete status in ukrainians.

Authors:  S B Drozdovska; V E Dosenko; I I Ahmetov; V N Ilyin
Journal:  Biol Sport       Date:  2013-07-22       Impact factor: 2.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.